Market revenue in 2023 | USD 3.5 million |
Market revenue in 2030 | USD 4.5 million |
Growth rate | 3.7% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | Reading and Analytical Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.57% in 2023. Horizon Databook has segmented the Saudi Arabia clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
The Saudi Food & Drug Administration (SFDA) is responsible for regulating use and marketing of medicinal products for human use. Under its guidance, all clinical trials must comply with Royal Act (M/6) dated (235/1/14228 H) and regulations of Pharmaceutical Facilities and Products (M/31) dated (1/6/1425H0).
It is mandatory to register all clinical trials at SFDA, drug sector, clinical trials department. Only trial sponsor, principal investigator, or Clinical Trial Monitoring Centre (CTMC) registered in Saudi Arabia may be registered to conduct clinical trials It is mandatory to obtain import license from SFDA for all investigational drugs imported into Saudi Arabia.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account